IMKTA vs MRNA · P/E 20, rev $5.33B vs rev $145.0M
Ingles Markets Incorporated (IMKTA) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Ingles Markets Incorporated (IMKTA) is a grocery stores company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported IMKTA revenue for 2025-09-27 was $5.33B. Net income was $83.6M. IMKTA currently screens at market cap $1.25B and trailing P/E 20.2.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
IMKTA currently screens at market cap $1.25B and trailing P/E 20.2. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the IMKTA and MRNA stock pages for the full models.
Not investment advice.